Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
100 项与 Lachlan Pharma Holdings Unlimited Co. 相关的临床结果
0 项与 Lachlan Pharma Holdings Unlimited Co. 相关的专利（医药）
100 项与 Lachlan Pharma Holdings Unlimited Co. 相关的药物交易
100 项与 Lachlan Pharma Holdings Unlimited Co. 相关的转化医学
